Claritev Corp
No enriched coverage for $CTEV in the last 7 days.
Claritev Corporation was chosen by General Dynamics Information Technology (GDIT) to support the CDC's World Trade Center Health Program. Claritev will use its provider network to administer care for responders and survivors of 9/11, focusing on network development and provider access.
Claritev Corporation (NYSE: CTEV) appointed Ben Letham to its Board of Directors, effective September 14, 2026. Letham, a research scientist at Meta (Nasdaq: META), brings expertise in AI and optimization systems. The company aims to leverage his experience to support its AI-driven growth strategy in healthcare technology.
Claritev Corp (CTEV) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Claritev Appoints Ben Letham to its Board of Directors Board gains deep technology and innovation expertise to support Claritev’s tech-driven growth strategy McLean, VA — September 15, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and
Recent CTEV coverage spans earnings, insider activity and corporate actions.
In the last 30 days, CTEV insiders filed 4 SEC Form 4 transactions — 2 purchases ($250K) and 2 sales ($276K). The most active reporter was Dalton Travis, Pres., CEO & Executive Chair, with 2 filings. 50% of those filings were made under pre-arranged Rule 10b5-1 plans.
Claritev Corporation was chosen by General Dynamics Information Technology (GDIT) to support the CDC's World Trade Center Health Program. Claritev will use its provider network to administer care for responders and survivors of 9/11, focusing on network development and provider access.
Board addition adds AI expertise; modest impact on share price.
Board addition may signal strategic focus on AI but no immediate financial impact.
Earnings beat and raised guidance boost upside, while thin cash balance raises downside risk.
Insider purchase signals confidence but size is modest.
AlphAI scores every news story that mentions CTEV with an AI model for sentiment and relevance, and aggregates insider trades from Claritev Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Claritev Corporation was chosen by General Dynamics Information Technology (GDIT) to support the CDC's World Trade Center Health Program. Claritev will use its provider network to administer care for responders and survivors of 9/11, focusing on network development and provider access.
1 min readClaritev Corporation (NYSE: CTEV) appointed Ben Letham to its Board of Directors, effective September 14, 2026. Letham, a research scientist at Meta (Nasdaq: META), brings expertise in AI and optimization systems. The company aims to leverage his experience to support its AI-driven growth strategy in healthcare technology.
2 min readClaritev Corp (CTEV) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Claritev Appoints Ben Letham to its Board of Directors Board gains deep technology and innovation expertise to support Claritev’s tech-driven growth strategy McLean, VA — September 15, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and
1 min readClaritev (CTEV) reported Q2 revenue of $257.5M, up 6.6%, raising full-year guidance to $1B-$1.02B. Adjusted EBITDA rose 1.1% to $155.8M, but net loss narrowed to $59.2M. Free cash flow doubled to $54.6M, yet unrestricted cash fell to $14.4M. Hedge fund ownership increased, and short interest is 9.03%.
2 min readDalton Travis (Pres., CEO & Executive Chair) purchased 6,450 indirectly-held shares of Claritev Corp (CTEV) at an average of $38.71 ($38.48–$38.81, $0.25M total) across 2 trades over 2026-08-27 to 2026-08-28.
1 min readMisencik Tiffani (SVP, Chief Growth Officer) sold 8,850 shares of Claritev Corp (CTEV) at $40.07 ($0.35M total) on 2026-08-14.
1 min readMintz William B. (SVP, Chief Strategy Officer) sold 8,431 shares of Claritev Corp (CTEV) at $34.24 ($0.29M total) on 2026-08-10.
1 min readPiper Sandler raised its price target for Claritev (NYSE:CTEV) to $73 from $61 and kept an Overweight rating. The stock was about $35.39. The firm cited platform and operating infrastructure improvements, a 1.4 million provider network, and expects profitability in fiscal 2026 with EPS forecast of $5.83.
4 min readClaritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.
5 min readClaritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202
6 min read
